Live Breaking News & Updates on Biotie Therapies

Stay updated with breaking news from Biotie therapies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Acorda Therapeutics (ACOR) Announces Revised Long-Term Financial Guidance

Acorda Therapeutics (ACOR) Announces Revised Long-Term Financial Guidance
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Tierney Saccavino , Therapy Qual Research Jan , Acorda Therapeutics , Exchange Commission , National Coverage Data , Acorda Therapeutics Inc , Biotie Therapies Ltd , Wall Street , Biotie Therapies , Assumptions Underlying Business Plan , Guidance Remain , Ending Cash Balance , Cash Flow , Extended Release Tablets , Demand Therapy Qual Research Jan ,

Acorda Therapeutics Enters into License Agreement with Asieris Pharmaceuticals

29.08.2022 - Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it has entered into a license agreement relating to its preclinical asset, Nepicastat, with Asieris Pharmaceuticals, a biotechnology company headquartered in China. Under the terms of the . Seite 1 ....

Asieris Pharmaceuticals , Biotie Therapies Inc , Acorda Therapeutics Inc , Acorda Therapeutics , Biotie Therapies ,